Literature DB >> 35955832

Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV Inhibitor.

Rachele Francese1, Claudio Cecone2, Matteo Costantino1, Gjylije Hoti2, Pierangiola Bracco2, David Lembo1, Francesco Trotta2.   

Abstract

Cyclodextrins and cyclodextrin derivatives were demonstrated to improve the antiviral potency of numerous drugs, but also to be endowed with intrinsic antiviral action. They are suitable building blocks for the synthesis of functionalized polymer structures with potential antiviral activity. Accordingly, four water-soluble hyper-branched beta cyclodextrin (βCD)-based anionic polymers were screened against herpes simplex virus (HSV-2), respiratory syncytial virus (RSV), rotavirus (HRoV), and influenza virus (FluVA). They were characterized by FTIR-ATR, TGA, elemental analyses, zeta-potential measurements, and potentiometric titrations, while the antiviral activity was investigated with specific in vitro assays. The polymer with the highest negative charge, pyromellitic dianhydride-linked polymer (P_PMDA), showed significant antiviral action against RSV and HSV-2, by inactivating RSV free particles and by altering HSV-2 binding to the cell. The polymer fraction with the highest molecular weight showed the strongest antiviral activity and both P_PMDA and its active fractions were not toxic for cells. Our results suggest that the polymer virucidal activity against RSV can be exploited to produce new antiviral materials to counteract the virus dissemination through the air or direct contact. Additionally, the strong HSV-2 binding inhibition along with the water solubility of P_PMDA and the acyclovir complexation potential of βCD are attractive features for developing new therapeutic topical options against genital HSV-2 infection.

Entities:  

Keywords:  antiviral agents; cyclodextrins; herpesvirus; polymers; respiratory syncytial virus

Mesh:

Substances:

Year:  2022        PMID: 35955832      PMCID: PMC9369026          DOI: 10.3390/ijms23158701

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  55 in total

Review 1.  Cyclodextrins.

Authors:  Sergey V Kurkov; Thorsteinn Loftsson
Journal:  Int J Pharm       Date:  2012-07-05       Impact factor: 5.875

2.  Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations.

Authors:  Pravin Shende; Yogesh A Kulkarni; R S Gaud; Kiran Deshmukh; Roberta Cavalli; Francesco Trotta; Fabrizio Caldera
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

3.  Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity.

Authors:  Heegon Kim; Junhee Han; Ji-Ho Park
Journal:  J Control Release       Date:  2019-12-13       Impact factor: 9.776

4.  Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.

Authors:  Sulong Xiao; Longlong Si; Zhenyu Tian; Pingxuan Jiao; Zibo Fan; Kun Meng; Xiaoshu Zhou; Han Wang; Renyang Xu; Xu Han; Ge Fu; Yongmin Zhang; Lihe Zhang; Demin Zhou
Journal:  Biomaterials       Date:  2015-11-30       Impact factor: 12.479

5.  Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1.

Authors:  Z Liao; L M Cimakasky; R Hampton; D H Nguyen; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

6.  Synthesis and characterization of a hyper-branched water-soluble β-cyclodextrin polymer.

Authors:  Francesco Trotta; Fabrizio Caldera; Roberta Cavalli; Andrea Mele; Carlo Punta; Lucio Melone; Franca Castiglione; Barbara Rossi; Monica Ferro; Vincenza Crupi; Domenico Majolino; Valentina Venuti; Dominique Scalarone
Journal:  Beilstein J Org Chem       Date:  2014-11-06       Impact factor: 2.883

7.  Electrospun crosslinked poly-cyclodextrin nanofibers: Highly efficient molecular filtration thru host-guest inclusion complexation.

Authors:  Asli Celebioglu; Zehra Irem Yildiz; Tamer Uyar
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

Review 8.  Pathogenesis and virulence of herpes simplex virus.

Authors:  Shuyong Zhu; Abel Viejo-Borbolla
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

9.  Anti-Zika virus and anti-Usutu virus activity of human milk and its components.

Authors:  Rachele Francese; Andrea Civra; Manuela Donalisio; Nicola Volpi; Federica Capitani; Stefano Sottemano; Paola Tonetto; Alessandra Coscia; Giulia Maiocco; Guido E Moro; Enrico Bertino; David Lembo
Journal:  PLoS Negl Trop Dis       Date:  2020-10-07

10.  Correction: Braga et al. Cyclodextrins in Antiviral Therapeutics and Vaccines. Pharmaceutics 2021, 13, 409.

Authors:  Susana Santos Braga; Jéssica S Barbosa; Nádia E Santos; Firas El-Saleh; Filipe A Almeida Paz
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.